Abstract:One of the hallmarks of the LH induced granulosa-luteal transition is a conversion from a proliferative, estrogen producing granulosa cell to a differentiated, progestin secreting luteal cell. The B Cell Translocation Gene (BTG) family has been reported to be involved in cell differentiation, antiproliferation, and gene transcription regulation. We hypothesized that BTGs are involved in this process, however, very little is known about them in the ovary. The present study investigated the spatiotemporal expression pattern, regulation and potential function of BTG1, BTG2, and BTG3 in the rat ovary during the periovulatory period. Immature 22-23 days old rats were injected with eCG (10 IU) s.c. to stimulate follicular development and 48h later with hCG (5 IU) s.c. to induce ovulation and subsequent formation of corpora lutea (CL). Animals were killed at different time points after hCG administration (n=3/time point). Ovaries were collected for isolation of total RNA or protein, or processed for in situ hybridization. Granulosa cells were also collected in vivo at different time points for isolation of total RNA or protein. Quantitative real-time PCR analysis revealed that mRNA for Btg1, Btg2, and Btg3 was highly induced both in intact ovaries and granulosa cells by 4 to 8h after hCG stimulation. The expression of Btg1 mRNA in whole ovary was highest between 4 and 8h before decreasing to control levels by 12 and 24h after hCG. The levels of Btg1 mRNA exhibited a similar expression pattern in the granulosa cells (in vivo) to that observed in the whole ovary with the highest expression at 8h. Btg2 mRNA expression in whole ovaries increased 6.5 fold at 4 and 8h after hCG but did not decrease to control levels by 24h, whereas its expression in the granulosa cells (in vivo) continued to increase until 24h after hCG treatment. Btg3 mRNA levels increased 3 fold at 8h after hCG and remained elevated throughout the periovulatory period in both granulosa cells (in vivo) and the whole ovary. In situ hybridization showed that Btg1 mRNA expression was induced in the theca and granulosa cells of some follicles at 4h after hCG injection. Strikingly, there was a switch in the expression from the theca to the granulosa cell compartment at 8 and 12h after hCG. After ovulation, Btg1 mRNA expression was similar to the 0h ovary with little detectable signal in the forming CL. In contrast, Btg2 mRNA expression level was high in luteal cells at 24h after hCG administration. Btg3 mRNA was induced at 8h in granulosa cells after hCG treatment. Regulation of Btg expression was then examined using cultured granulosa cells. Inhibition of progesterone action and the EGF pathway did not change Btg1 and Btg2 mRNA expression, whereas inhibition of prostaglandin synthesis or RUNX activity diminished Btg2 mRNA levels. To determine the function of the BTGs, overexpression of BTG1 or BTG2 resulted in an increase in the percentage of granulosa cells in the G0/G1 phase, whereas the percentage of cells in the S phase decreased. The apoptosis rate in the granulosa cells overexpressing BTG1 or BTG2 also decreased compared to cells infected with the control GFP vector. In conclusion, the induction of BTG1, BTG2, and BTG3 expression after hCG administration and the ability to arrest the cell cycle may be related to theca and granulosa cells differentiation or the establishment of quiescence. (Supported by NIH RR15592 and AG17164)

Expression of BTG1 in HK-2 and 786-O and Its Influence on Cell Cycle and Apoptosis of HK-2 and 786-O

The effect of BTG1 expression on proliferation, apoptosis and invasion of non-small cell lung cancer cells

Expression of recombinant BC047440 protein and its effects on proliferation of HepG2 cells in vitro

The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis

The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis

Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma

BTG1 Overexpression Might Promote Invasion and Metastasis of Colorectal Cancer via Decreasing Adhesion and Inducing Epithelial–Mesenchymal Transition

Overexpression of PlK-1 gene effects of PlK-1 gene on the chemotherapeutic sensitivity of pancreatic carcinoma cell line AsPC-1 response to gemcitabine

The B Cell Translocation Gene (BTG) Family in the Rat Ovary: Hormonal Induction, Regulation, and Impact on Cell Cycle Kinetics.

Effect of NUP88 gene on proliferation and invasion biological behavior of breast cancer cell line BT-20

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer

TuBG1 promotes hepatocellular carcinoma via ATR/P53-apoptosis and cycling pathways

Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma

Effects of TIEG1 on K562 Cell Apoptosis and Expression of BCL-2/BAX,PTEN

Cell Surface Beta 1,4-Galactosyltransferase 1 Promotes Apoptosis by Inhibiting Epidermal Growth Factor Receptor Pathway

The clinical significance and anti-tumor role of PRKG1 in bladder cancer

The Construction of Gallbladder Carcinoma Cell Line GBC-SD with Stable Expression of DMBT1 and Its Growth Properties HE Too

Overexpression of the Kininogen-1 Inhibits Proliferation and Induces Apoptosis of Glioma Cells

53BP1 Suppresses Tumor Growth and Promotes Susceptibility to Apoptosis of Ovarian Cancer Cells Through Modulation of the Akt Pathway.

Plasma exosome-derived B-cell translation gene 1: a predictive marker for the prognosis in patients with non-small cell lung cancer

Transcriptomic Analyses Reveal B-Cell Translocation Gene 2 as a Potential Therapeutic Target in Ovarian Cancer